Symbiox Investment & Trading Co Ltd Stock Price Today (NSE: SYMBIOX)
Fundamental Score
Symbiox Investment & Trading Co Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Symbiox Investment & Trading Co Ltd share price today is ₹1.70, up +0.00% on NSE/BSE as of 19 June 2026. Symbiox Investment & Trading Co Ltd (SYMBIOX) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹8.67 (Cr). The 52-week high for SYMBIOX share price is ₹3.70 and the 52-week low is ₹1.36. The company has a Return on Equity (ROE) of 0.60% and a debt-to-equity ratio of 0.00.
Symbiox Investment & Trading Co Ltd Share Price Chart — NSE/BSE Historical Performance
Symbiox Investment & Trading Co Ltd share price chart: -10.75% return over the past month. 52-week high ₹3.70, 52-week low ₹1.36.
Symbiox Investment & Trading Co Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1.70 | ₹1.70 | ₹1.70 | ₹1.70 | 4.20K (Cr) | |
| ₹1.73 | ₹1.73 | ₹1.67 | ₹1.70 | 4.64K (Cr) | |
| ₹1.67 | ₹1.73 | ₹1.67 | ₹1.73 | 8.71K (Cr) | |
| ₹1.69 | ₹1.69 | ₹1.66 | ₹1.66 | 31.58K (Cr) | |
| ₹1.77 | ₹1.77 | ₹1.69 | ₹1.69 | 29.79K (Cr) | |
| ₹1.79 | ₹1.79 | ₹1.73 | ₹1.77 | 4.35K (Cr) | |
| ₹1.72 | ₹1.73 | ₹1.72 | ₹1.72 | 34.85K (Cr) | |
| ₹1.72 | ₹1.80 | ₹1.72 | ₹1.77 | 9.18K (Cr) | |
| ₹1.85 | ₹1.85 | ₹1.77 | ₹1.80 | 2.37K (Cr) | |
| ₹1.89 | ₹1.89 | ₹1.85 | ₹1.85 | 10.19K (Cr) |
Symbiox Investment & Trading Co Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1.73 | ₹1.73 | ₹1.67 | ₹1.70 | -1.73% | |
| ₹1.78 | ₹1.90 | ₹1.66 | ₹1.73 | -2.81% | |
| ₹1.46 | ₹2.07 | ₹1.36 | ₹1.77 | +21.23% | |
| ₹1.72 | ₹1.89 | ₹1.46 | ₹1.46 | -15.12% | |
| ₹1.84 | ₹2.19 | ₹1.70 | ₹1.86 | +1.09% | |
| ₹1.72 | ₹2.07 | ₹1.64 | ₹1.85 | +7.56% | |
| ₹2.77 | ₹2.94 | ₹1.81 | ₹1.81 | -34.66% | |
| ₹2.98 | ₹3.10 | ₹2.75 | ₹2.77 | -7.05% | |
| ₹2.70 | ₹3.70 | ₹2.15 | ₹2.98 | +10.37% | |
| ₹2.91 | ₹3.00 | ₹2.65 | ₹2.80 | -3.78% | |
| ₹2.68 | ₹3.24 | ₹2.33 | ₹2.91 | +8.58% | |
| ₹2.74 | ₹2.89 | ₹2.42 | ₹2.63 | -4.01% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Micro-cap textile trader with zero profits, declining sales, and minimal promoter holding is a value trap, not a turnaround.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Trading window closed on April 1, 2026, until 48 hours after FY26 results. Stock is near its 52-week low, hitting on March 27, 2026.
CORE STORY (THE REAL GAME)
This is a micro-cap textile trading and investment company. The market narrative seems to be a potential turnaround play, fueled by hopes of improved financial performance, despite weak fundamentals and declining sales.
- Trading window closure implies results are imminent
- Stock near 52-week low
- High retail 'Buy' recommendations
- Unexpectedly strong FY26 results
- Major order win
- Significant promoter buying
- Micro/SME cap = liquidity risk
- Zero net profit
- Declining sales
- Minimal promoter holding (3.33%)
No institutional investors. Promoter holding is negligible (3.33%).
NBFC sector projected to grow, but smaller players face funding and regulatory challenges.
No. Negative free cash flow of ₹-3.17 Cr over 5 years.
Next 3-6 months hinges on FY26 results. Expect volatility and potential downside if results disappoint.
Primary Thesis Risk
Lack of profitability and declining sales will eventually lead to capital erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Symbiox Investment & Trading Co Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Symbiox Investment & Trading Co Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SYMBIOX across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Consistent Growth Track Record (21.64% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (56.87% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (56.87% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (0.60%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.82%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-0.07%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-81.82%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-69.33%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-3.17 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (3.33%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Symbiox Investment & Trading Co Ltd vs Other Financial Services Peers
Peer Comparison - Other Financial Services
Compare Symbiox Investment & Trading Co Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Symbiox Investment & Trading Co LtdSymbiox Investm...Selected✓ SYMBIOX • 539278 | 22.1/100 | ₹1.70₹2 | ₹8.67₹8.67 | — — | 0.60%Poor 0.60% Poor | 0.82%Poor 0.82% Poor | 0.00Excellent 0.0 Excellent | 56.87%Excellent 56.87% Excellent | 21.64%Excellent 21.64% Excellent | 0.00% |
Crisil LtdCrisil Ltd... CRISIL • 500092 | 64/100 | ₹3987.30₹3987 | ₹32833.08₹32833.08 | 43.82Average 43.8 Average | 27.81%Excellent 27.81% Excellent | 35.60%Excellent 35.60% Excellent | 0.11Excellent 0.1 Excellent | 14.43%Good 14.43% Good | 13.49%Good 13.49% Good | 0.56% |
RRPSemiconductorRRPSemiconducto... RRPS • 504346 | 21.2/100 | ₹11320.20₹11320 | ₹15422.64₹15422.64 | — — | 208.63%Excellent 208.63% Excellent | 80.21%Excellent 80.21% Excellent | 1.56Average 1.6 Average | 179.71%Excellent 179.71% Excellent | — — | 0.00% |
COLAB PLATFORMS LIMITEDCOLAB PLATFORMS... COLAB • 542866 | 53.3/100 | ₹153.55₹154 | ₹4011.66₹4011.66 | 864.58Average 864.6 Average | 12.36%Average 12.36% Average | 16.59%Good 16.59% Good | 0.00Excellent 0.0 Excellent | 79.86%Excellent 79.86% Excellent | 188.59%Excellent 188.59% Excellent | 0.01% |
Dhani Services LtdDhani Services ... DHANI • 532960 | 20.9/100 | ₹51.06₹51 | ₹3896.81₹3896.81 | 114.92Average 114.9 Average | -1.81%Poor -1.81% Poor | 1.39%Poor 1.39% Poor | 0.18Excellent 0.2 Excellent | — — | -32.89%Poor -32.89% Poor | 0.00% |
ALGOQUANTALGOQUANT... ALGOQUANT • 505725 | 6.9/100 | ₹56.73₹57 | ₹1689.95₹1689.95 | 102.86Average 102.9 Average | 37.55%Excellent 37.55% Excellent | 32.47%Excellent 32.47% Excellent | 0.24Excellent 0.2 Excellent | — — | — — | 0.00% |
LKP Finance LtdLKP Finance Ltd... LKPFIN • 507912 | 1.7/100 | ₹189.35₹189 | ₹1396.38₹1396.38 | — — | -0.17%Poor -0.17% Poor | -0.83%Poor -0.83% Poor | 0.06Excellent 0.1 Excellent | 14.57%Good 14.57% Good | -17.45%Poor -17.45% Poor | 0.00% |
Centrum Capital LtdCentrum Capital... CENTRUM • 501150 | 0/100 | ₹22.65₹23 | ₹1369.10₹1369.10 | — — | -57.60%Poor -57.60% Poor | 8.93%Poor 8.93% Poor | 37.49Poor 37.5 Poor | — — | 47.25%Excellent 47.25% Excellent | 0.00% |
67.9/100 | ₹912.60₹913 | ₹1086.24₹1086.24 | 32.77Average 32.8 Average | 28.60%Excellent 28.60% Excellent | 37.87%Excellent 37.87% Excellent | 0.00Excellent 0.0 Excellent | 94.13%Excellent 94.13% Excellent | 43.40%Excellent 43.40% Excellent | 1.94% | |
Prime Securities LtdPrime Securitie... PRIMESECU • 500337 | 49/100 | ₹284.70₹285 | ₹998.77₹998.77 | 30.04Average 30.0 Average | 19.46%Good 19.46% Good | 22.62%Excellent 22.62% Excellent | 0.01Excellent 0.0 Excellent | 34.59%Excellent 34.59% Excellent | 3.63%Average 3.63% Average | 0.51% |
39.1/100 | ₹290.00₹290 | ₹890.53₹890.53 | 39.02Average 39.0 Average | 25.18%Excellent 25.18% Excellent | 29.45%Excellent 29.45% Excellent | 0.27Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Other Financial Services Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Crisil Ltd share price32833.08 Cr
- RRPSemiconductor share price15422.64 Cr
- COLAB PLATFORMS LIMITED share price4011.66 Cr
- Dhani Services Ltd share price3896.81 Cr
- ALGOQUANT share price1689.95 Cr
Symbiox Investment & Trading Co Ltd PE Ratio History
Historical price-to-earnings ratio for SYMBIOX — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.06 | ₹1.81 | 29.7x |
| FY 2024 | ₹0.07 | ₹5.42 | 80.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Symbiox Investment & Trading Co Ltd Quarterly Performance
Latest quarterly metrics for SYMBIOX — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-69.33%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-81.82%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.64%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
56.87%
Compounded annual net profit growth over 5 years
Symbiox Investment & Trading Co Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SYMBIOX — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Symbiox Investment & Trading Co Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Symbiox Investment & Trading Co Ltd (SYMBIOX) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Symbiox Investment & Trading Co Ltd
About SYMBIOX (Symbiox Investment & Trading Co Ltd)
Symbiox Investment & Trading Co Ltd is a dynamic entity operating within the Other Financial Services sector, actively cultivating a diversified portfolio of strategic investments ...and trade-related activities. The company distinguishes itself through its nimble approach to identifying and capitalizing on emerging market opportunities, driven by in-depth market research and a commitment to fostering sustainable growth. Symbiox operates with a focus on building strong partnerships and leveraging its extensive network to facilitate seamless transactions and maximize value creation across its varied ventures. The company is committed to adhering to the highest standards of ethical conduct and regulatory compliance, ensuring transparency and accountability in all its business dealings. At the core of Symbiox’s operations lies a commitment to fostering financial innovation and efficiency. The company actively explores and integrates cutting-edge technologies and methodologies to optimize its investment strategies and streamline its trading processes. This proactive approach enables Symbiox to adapt quickly to evolving market dynamics and maintain a competitive edge in the ever-changing financial landscape. Furthermore, Symbiox recognizes the importance of nurturing talent and fostering a collaborative work environment. The company invests in its employees, providing them with opportunities for professional development and empowering them to contribute to the company's overall success. Symbiox Investment & Trading Co Ltd distinguishes itself through its commitment to delivering exceptional value to its stakeholders. By combining a strategic focus on identifying lucrative investment opportunities with a dedication to operational excellence, the company strives to generate consistent and sustainable returns. Symbiox is dedicated to upholding the highest standards of integrity and ethical conduct in all its business dealings. By prioritizing transparency, accountability, and responsible corporate citizenship, Symbiox aims to build long-term trust and strong relationships with its partners, clients, and the broader community.
Company Details
Key Leadership
SYMBIOX Share Price: Frequently Asked Questions
What is the current share price of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd (SYMBIOX) trades at ₹1.70 on NSE and BSE. Market cap ₹8.67 (Cr). Educational data only.
What is the P/E ratio of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has a P/E of N/Ax vs industry average 30.94x.
What is the Bull Run score for Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has a Bull Run score of 22.1/100 based on 25+ financial parameters.
Does Symbiox Investment & Trading Co Ltd pay dividends?
Symbiox Investment & Trading Co Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has ROE of 0.60%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has debt-to-equity of 0.00.
Is Symbiox Investment & Trading Co Ltd a good investment?
Bull Run gives Symbiox Investment & Trading Co Ltd a score of 22.1/100. This is not investment advice — consult a SEBI-registered advisor.